Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT ID: NCT07100912
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
113 participants
INTERVENTIONAL
2025-08-18
2025-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT05079607
Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT06884215
HRIPT Study to Evaluate the Irritation and Allergenic Potential of Medical-grade Norway Spruce (Picea Abies) Resin Salve (Abilar)
NCT06810856
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
NCT03406117
HRIPT for Collagen Dressing
NCT06283173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mitopure Topical Formula
Mitopure Topical Formula 5
Topical skin cream containing Mitopure
Mitopure Topical Formula 6
Topical skin cream containing Mitopure
Mitopure Topical Formula 7
Topical skin cream containing Mitopure
Mitopure Topical Formula 8
Topical skin serum containing Mitopure
Mitopure Topical Formula 9
Topical skin exfoliator containing Mitopure
Mitopure Topical Formula 10
Topical skin cleanser containing Mitopure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mitopure Topical Formula 5
Topical skin cream containing Mitopure
Mitopure Topical Formula 6
Topical skin cream containing Mitopure
Mitopure Topical Formula 7
Topical skin cream containing Mitopure
Mitopure Topical Formula 8
Topical skin serum containing Mitopure
Mitopure Topical Formula 9
Topical skin exfoliator containing Mitopure
Mitopure Topical Formula 10
Topical skin cleanser containing Mitopure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed written informed consent.
* Female subject agrees to use an acceptable method of birth control (e.g. abstinence, condoms, hormonal birth control, IUD, tubal ligation, hysterectomy, bilateral oophorectomy, hysterectomy, post-menopausal for at least one year or male partner vasectomy).
Exclusion Criteria
* Participation in a repeat insult patch test (RIPT) or follow-up work within the last month.
* Current treatment by a physician for allergy unless physician consulted by Investigator and participation approved.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Princeton Consumer Research
OTHER
Amazentis SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PCR Corp
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASARIP3M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.